Background and Rationale Patients with hereditary hemorrhagic telangiectasia (HHT) are at risk for vascular malformations in the brain, lungs, and liver. Current guidelines for AVM screening in HHT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback